Chekroud, A M
Koutsouleris, N
Article History
Received: 19 June 2017
Revised: 9 August 2017
Accepted: 25 September 2017
First Online: 7 November 2017
Competing interests
: AMC holds equity in Spring Care Inc., a behavioral health startup. He received salary from Spring Care Inc. and Yale University. He is lead inventor on two patent submissions relating to treatment for major depressive disorder ((a) USPTO docket number Y0087.70116US00, and (b) USPTO. Provisional Appl. No. 62/491,660). He has consulted for Fortress Biotech on antidepressant drug development. NK has received paid speakerships from Otsuka/Lundbeck, and holds a patent relating to psychosis risk prediction (USPTO Appl. No. 14/910588).